Fundraising FoxAmplitude Venture Capital — Full Portfolio
22 tracked investments · listed companies and verified rows first
Zymeworks is a biotechnology company that develops novel therapeutics for patients with difficult-to-treat diseases using its proprietary drug-development platforms and in-house R&D.
BiotechHealthtechVancouver, US
ALI TEHRANI(Executive Officer, Director)inGORDON NG(Executive Officer)NEIL KLOMPAS(Executive Officer)inSURJIT DIXIT(Executive Officer)inDAVID TUCKER(Executive Officer)Paul Moore(Chief Scientific Officer)in
Co-investorsBrace PharmaCTI Life Sciences Fund L.P.HBM Healthcare InvestmentsLumira VenturesNextech InvestWUTIF Capital
Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.
BiotechDigital HealthHealthtechMedical DevicesMontreal, US
Ela Borenstein(Director)Francis Plat(Executive Officer)Yves Rosconi(Director)Scott Weiner(Director)Martin Maguire(Executive Officer)Philippe Douville(Executive Officer, Director)
Board seatDion Madsen· per SEC Form D · $6.9M raise · filed Jul 2017
Co-investorsPappas CapitalDomain AssociatesForbionRTW Investments L.P.
Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine.
HealthtechCambridge, US
Tariq Kassum(Executive Officer, Director)inMichael Boretti(Executive Officer)inChristoph Lengauer(Executive Officer, Director)in
Co-investorsCatalio Capital Management, LPFast Track InitiativeGV (Google Ventures)AlexandriaCasdin CapitalThird Rock Ventures
Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico.
AI & Machine LearningBiotechDeep Tech
Clarissa Desjardins(Founder)in
Co-investorsOrbiMedAlexandriaDIMENSIONAngelini VenturesBDC Thrive Venture Fund for WomenLumira Ventures+1 more
Fluid Biomed develops a bioresorbable polymer-based stent designed to treat brain aneurysms by diverting blood flow and reducing risk of stroke.
BiotechDeep TechHealthtechMedical DevicesCalgary, CA
Dr. John H. Wong(Co-founder & Chief Executive Officer)Dr. Alim P. Mitha(Co-founder, President & Chief Technology Officer)
Co-investorsAccelerate FundLifeArc VenturesShangBay Capital LLCSymbiotic VenturesThin Air LabsUCeed Funds+1 more
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsAir Street CapitalLux CapitalObvious VenturesAmgen VenturesLeaps by Bayer
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical DevicesBoston, US
Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)inBrian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)
Co-investorsAgent CapitalGimvLongwood FundMission BiocapitalNovartis Venture FundOno Venture Investment, Inc.+5 more
Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies.
BiotechDeep TechHealthtechMedical DevicesMontreal, CA
Milad Dagher(Founder)inJeff Munzar(Founder)inElisha Krauss(Operations Manager)Ani Muradyan(Recruiter)
Co-investorsAvant BioFirst Star VenturesFront Row VenturesRaptor GroupY Combinator2048 Ventures+9 more
Prilenia is a biotechnology company developing treatments for neurodegenerative diseases, including Huntington's disease and amyotrophic lateral sclerosis (ALS).
BiotechHealthtechMedical Devices
Co-investorsALS Investment FundSV Health InvestorsForbion
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
Co-investorsFACIT (Fight Against Cancer Innovation Trust)Toronto Innovation Acceleration PartnersBill & Melinda Gates Foundation
Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds.
BiotechHealthtech
Co-investorsFinchley Healthcare VenturesInBC Investment Corp.Thin Air LabsKdT Ventures
Valence provides a trading terminal that unifies execution across prediction markets including Kalshi and Polymarket, routing orders intelligently across multiple venues to achieve optimal pricing.
FintechMarketplacesSan Francisco, US
Neo Wang(Founder)inDaniel Kasabov-Nouvion(Founder)inArthur Zhou(Founder)inParker Mitchell(Founder)
Co-investorsY CombinatorAlpha PartnersANIMO VenturesBessemer Venture PartnersDifferential VenturesFirstMark Capital+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Abdera TherapeuticsAbility biologicsCelciusEvolved TherapeuticsEvommuneGiiant PharmaImagiaTentarix BiotherapeuticsThryv Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.